Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.

about

Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus

P2860

Q57124195-A89EEA60-FAF4-4F04-956A-7100932B7E63

P2860

Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.

Item

http://www.wikidata.org/entity/Q47350202

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Darunavir/ritonavir monotherap ...... with suppressed HIV viraemia.

@en

Darunavir/ritonavir monotherapy at a low dose

@nl

type

Item

label

Darunavir/ritonavir monotherap ...... with suppressed HIV viraemia.

@en

Darunavir/ritonavir monotherapy at a low dose

@nl

prefLabel

Darunavir/ritonavir monotherap ...... with suppressed HIV viraemia.

@en

Darunavir/ritonavir monotherapy at a low dose

@nl

P1476

Darunavir/ritonavir monotherap ...... with suppressed HIV viraemia.

@en

P2093

A-G Marcelin

http://www.w3.org/2001/XMLSchema#string

C Soulie

http://www.w3.org/2001/XMLSchema#string

F Caby

http://www.w3.org/2001/XMLSchema#string

G Peytavin

http://www.w3.org/2001/XMLSchema#string

L Assoumou

http://www.w3.org/2001/XMLSchema#string

L Schneider

http://www.w3.org/2001/XMLSchema#string

M P Lê

http://www.w3.org/2001/XMLSchema#string

M-A Valantin

http://www.w3.org/2001/XMLSchema#string

R Calin

http://www.w3.org/2001/XMLSchema#string

R Tubiana

http://www.w3.org/2001/XMLSchema#string

P2860

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patients.

Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial.

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial.

Individualized antiretroviral therapeutic approaches: less can be more.

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

P31

scholarly article

P356

10.1093/JAC/DKX417

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Christine Katlama

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29216346

http://www.w3.org/2001/XMLSchema#string

Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.

about

P2860

P2860

Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698